Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Cardiology›Diabetes Distress Scale (DDS)
Process / pipelinediabetes-specific emotional and psychosocial distress

Diabetes Distress Scale (DDS)

Also known as: DDS

The Diabetes Distress Scale (DDS) is a 17-item self-report measure that quantifies emotional and psychosocial distress specifically related to living with and managing diabetes. Developed by Polonsky and colleagues in 2005, the DDS captures diabetes-specific worries (e.g., regimen burden, fear of complications, social stigma, lack of support) that are distinct from generalized depression or anxiety, making it essential for identifying and addressing the emotional obstacles to optimal diabetes self-management.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Diabetes Distress Scale
Diabetes Self-Efficacy S…Hypoglycemia Fear SurveyProblem Areas in Diabete…

When to use it

The DDS is recommended for screening and monitoring all patients with type 1 or type 2 diabetes in primary care, endocrinology, cardiology (patients with diabetes and cardiovascular disease), and diabetes education programs. Specific indications include: (1) baseline screening at diabetes diagnosis or clinic enrollment to identify distress and inform psychosocial referral decisions, (2) periodic reassessment (annually or when glycemic control is poor despite apparent adherence) to detect emerging distress, (3) monitoring response to psychosocial interventions (diabetes education, supportive counseling, peer support groups), (4) research measuring impact of diabetes or interventions on emotional wellbeing, and (5) identifying barriers to care adherence, particularly in patients with suboptimal glycemic control and suspected psychosocial barriers rather than knowledge deficits.

Strengths & limitations

Strengths
  • Diabetes-specific: DDS measures distress unique to diabetes management, not generalized depression/anxiety, improving specificity for identifying modifiable emotional barriers.
  • Predictive of outcomes: DDS scores predict glycemic control (HbA1c), adherence, and satisfaction with care; higher distress is associated with worse glycemic control independent of education or socioeconomic status.
  • Brief and easy to use: 17 items, 5–7 minute administration, and simple scoring support real-world clinic integration.
  • Multidimensional subscales: four subscales pinpoint specific distress sources (regimen, physician, emotional, interpersonal), guiding targeted intervention rather than generic support.
  • Validated in diverse diabetes populations: established in type 1, type 2, gestational diabetes, and parents of children with diabetes.
Limitations
  • Psychometric overlap with depression: while designed as diabetes-specific, DDS correlates moderately with depressive symptoms (PHQ-9), limiting distinction from generalized mental illness in some populations.
  • Does not measure behavioral outcomes: DDS quantifies distress perception, not actual adherence or glycemic control; high distress does not guarantee that interventions will improve behavior.
  • Recall bias: items ask about typical experience over recent weeks, which may be influenced by recent events or emotional state at time of completion.
  • Cultural and language variation: validation data are primarily from English-speaking, high-income populations; cultural differences in expression of diabetes-related emotional burden may affect interpretation in diverse settings.
  • Not a diagnostic tool: DDS is a screening and monitoring measure; elevated scores do not diagnose depression, anxiety disorder, or other mental illness and should prompt further evaluation.

Frequently asked

How does DDS differ from PHQ-9 (depression screening)?

DDS measures diabetes-specific emotional burden (regimen distress, complication worry, physician relationship); PHQ-9 measures generalized depression (mood, pleasure loss, concentration, sleep). A patient may have elevated DDS (>3.0) but normal PHQ-9, indicating diabetes-specific distress without major depression. DDS may be more useful for diabetes clinic screening; PHQ-9 is appropriate for identifying diagnosable depression warranting antidepressant consideration.

What DDS score should trigger psychosocial referral?

DDS mean score ≥3.0 (total ≥51) warrants structured psychosocial assessment: diabetes education with behavior coaching, supportive counseling, peer support group, or mental health referral. Scores 2.0–2.9 indicate monitoring and offer lower-intensity support (educational materials, peer connections). Scores <2.0 typically require no specific psychosocial intervention beyond routine education.

Can DDS be used to monitor response to antidepressants in diabetic patients?

DDS can be used as an outcome measure but is not a substitute for depression screening (PHQ-9). Antidepressants typically improve generalized depressive symptoms (PHQ-9) and may indirectly reduce diabetes-specific distress by improving mood. However, DDS specifically measures management burden and regimen distress, which may persist despite antidepressant use; concurrent behavioral support (education, coaching) is often needed to address these.

Is DDS validated for type 2 diabetes managed with oral medications only?

Yes, DDS is validated in type 2 diabetes on oral medication, insulin, or combination therapy. Regimen-related distress may differ (oral regimen burden typically lower than insulin), but the four-subscale structure applies across treatment types. Interpretation thresholds are consistent across diabetes types and treatment modalities.

How often should DDS be repeated?

Baseline DDS is recommended at diabetes diagnosis or clinic enrollment. For patients with DDS <2.0, repeat annually. For DDS 2.0–3.0, repeat every 6 months or after major life changes. For DDS ≥3.0, repeat monthly or after psychosocial intervention to track improvement. Post-intervention DDS (2–4 weeks after education or counseling start) assesses initial response and guides further support.

Sources

  1. Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mulcahy, K., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care, 28(3), 626–631. DOI: 10.2337/diacare.28.3.626 ↗

How to cite this page

ScholarGate. (2026, June 3). Diabetes Distress Scale (DDS). ScholarGate. https://scholargate.app/en/cardiology/diabetes-distress-scale

Related methods

Diabetes Self-Efficacy ScaleHypoglycemia Fear SurveyProblem Areas in Diabetes Scale

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Diabetes Self-Efficacy ScaleCardiology↔ compare
  • Hypoglycemia Fear SurveyCardiology↔ compare
  • Problem Areas in Diabetes ScaleCardiology↔ compare
Compare side by side →

Referenced by

Diabetes Self-Efficacy ScaleHypoglycemia Fear SurveyProblem Areas in Diabetes Scale

Similar methods

Problem Areas in Diabetes ScaleHypoglycemia Fear SurveyDQOLDiabetes Symptom ChecklistDiabetes Self-Efficacy ScalePedsQL Diabetes ModuleClarke Hypoglycemia Awareness QuestionnaireDepression Anxiety Stress Scales

Related reference concepts

DiabetesDepression and Anxiety Disorder ScreeningDepression and Anxiety ScreeningHealth Psychology TestingDiabetes and Endocrine Disorders ManagementPsychosocial Wellbeing in Pregnancy

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Diabetes Distress Scale (Diabetes Distress Scale (DDS)). Retrieved 2026-07-21 from https://scholargate.app/en/cardiology/diabetes-distress-scale · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
William H. Polonsky
Subfamily
diabetes-specific emotional and psychosocial distress
Year
2005
Type
Self-report questionnaire
Related methods
Diabetes Self-Efficacy ScaleHypoglycemia Fear SurveyProblem Areas in Diabetes Scale
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account